INTERNATIONAL AIDS VACCINE INITIATIVE INC: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
INTERNATIONAL AIDS VACCINE INITIATIVE INC (EIN 13-3870223)
Tax period
2018-01-01 to 2018-12-31
Filed
2019-06-27
IRS object ID
201931789349300713
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2019-06-27T09:22:16-05:00ReturnTs
Tax Period End2018-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN521392008PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GELMAN ROSENBERG & FREEDMANBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14550 MONTGOMERY AVE SUITE 650NAddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208142930ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2018-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133870223EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1INTERNATIONAL AIDS VACCINEBusinessNameLine1Txt
Business Name Line2INITIATIVE INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlINTEBusinessNameControlTxt
Phone2128471111PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1125 BROAD STREET NO 9TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonLOUIS D SCHWARTZPersonNm
Person TitleCFOPersonTitleTxt
Phone2128471111PhoneNum
Signature2019-06-27SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Phone3019519090PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address75.103.231.202IPv4AddressTxt
FieldValueIRS element (for citing)
IP2019-06-27IPDt
IP Tm10:22:09IPTm
IP TimezoneEDIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id0D15A491995E46E808D52BD8C9630571FBE28805AtSubmissionCreationDeviceId
At Submission Filing Device Id2B7A9914EAA8F2914D3ACF7576175A6968A24A30AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2019-02-21 02:37:17ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerMARK FEINBERGPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1125 BROAD STREET NO 9TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$77,192,773GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.IAVI.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1996FormationYr
Legal Domicile StateDELegalDomicileStateCd
Activity Or MissionTRANSLATE SCIENTIFIC DISCOVERIES INTO AFFORDABLE, GLOBALLY ACCESSIBLE PUBLIC HEALTH SOLUTIONSActivityOrMissionDesc
Voting Members Governing Body15VotingMembersGoverningBodyCnt
Voting Members Independent14VotingMembersIndependentCnt
Total Employee196TotalEmployeeCnt
Total Volunteers14TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$132,012NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$79,435,403PYContributionsGrantsAmt
CY Contributions Grants$75,524,844CYContributionsGrantsAmt
PY Program Service Revenue$260,438PYProgramServiceRevenueAmt
CY Program Service Revenue$396,577CYProgramServiceRevenueAmt
PY Investment Income$596,174PYInvestmentIncomeAmt
CY Investment Income$921,661CYInvestmentIncomeAmt
PY Other Revenue$234,949PYOtherRevenueAmt
CY Other Revenue$349,691CYOtherRevenueAmt
PY Total Revenue$80,526,964PYTotalRevenueAmt
CY Total Revenue$77,192,773CYTotalRevenueAmt
PY Grants And Similar Paid$17,623,273PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$18,701,603CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$27,029,476PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$29,819,824CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,234,999CYTotalFundraisingExpenseAmt
PY Other Expenses$40,744,716PYOtherExpensesAmt
CY Other Expenses$34,861,623CYOtherExpensesAmt
PY Total Expenses$85,397,465PYTotalExpensesAmt
CY Total Expenses$83,383,050CYTotalExpensesAmt
PY Revenues Less Expenses-$4,870,501PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$6,190,277CYRevenuesLessExpensesAmt
Total Assets BOY$81,959,513TotalAssetsBOYAmt
Total Assets EOY$83,382,669TotalAssetsEOYAmt
Total Liabilities BOY$38,044,228TotalLiabilitiesBOYAmt
Total Liabilities EOY$46,200,945TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$43,915,285NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$37,181,724NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionA NONPROFIT SCIENTIFIC RESEARCH ORGANIZATION DEDICATED TO ADDRESSING URGENT, UNMET GLOBAL HEALTH CHALLENGES INCLUDING HIV AND TUBERCULOSIS. THE ORGANIZATION'S MISSION IS TO TRANSLATE SCIENTIFIC DISCOVERIES INTO AFFORDABLE, GLOBALLY ACCESSIBLE PUBLIC HEALTH SOLUTIONS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$60,048,929ExpenseAmt
Grant$17,668,949GrantAmt
DescRESEARCH AND DEVELOPMENT: THROUGH SCIENTIFIC AND CLINICAL RESEARCH IN AFRICA, INDIA, EUROPE, AND THE U.S., IAVI DEVELOPS VACCINES AND ANTIBODIES IN AND FOR THE DEVELOPING WORLD AND SEEKS TO ACCELERATE THEIR INTRODUCTION IN LOW-INCOME COUNTRIES. IAVI ADVANCES SCIENTIFIC DISCOVERY AND DEVELOPMENT BY FOSTERING UNIQUE COLLABORATIONS AMONG ACADEMIA, INDUSTRY, LOCAL COMMUNITIES, GOVERNMENTS, AND FUNDERS TO EXPLORE NEW AND BETTER WAYS TO ADDRESS PUBLIC HEALTH THREATS THAT DISPROPORTIONATELY AFFECT PEOPLE LIVING IN POVERTY. VACCINE AND ANTIBODY CANDIDATES ARE PUT THROUGH A RIGOROUS PROCESS OF CLINICAL EVALUATION AMONG KEY POPULATIONS TO ESTABLISH THEIR SAFETY AND EFFICACY, AN EFFORT THAT ENABLES IAVI TO STRENGTHEN THE HEALTHCARE INFRASTRUCTURE AND SCIENTIFIC CAPACITY OF COUNTRIES WHERE OUR CLINICAL PARTNERS OPERATE. TO DATE, IAVI AND ITS PARTNERS HAVE ADVANCED MORE THAN 30 HIV VACCINE CANDIDATES INTO EARLY STAGE CLINICAL TRIALS. THIS INCLUDES THE FIRST HIV VACCINE TRIALS IN SUB-SAHARAN COUNTRIES, WHERE THE HIV BURDEN IS GREATEST. IAVI HAS CONDUCTED 47 EPIDEMIOLOGICAL STUDIES AND PROVIDED VOLUNTARY HIV TESTING AND COUNSELING SERVICES TO MORE THAN 790,000 INDIVIDUALS IN AFRICA. IAVI ALSO SUPPORTS PRECLINICAL DEVELOPMENT AND CLINICAL TESTING OF VACCINE CANDIDATES FOR OTHER DISEASES, INCLUDING TUBERCULOSIS AND LASSA FEVER, AS WELL AS ANTIBODY CANDIDATES FOR DISEASE PREVENTION AND TREATMENT. IAVI CONDUCTS TRIALS WITH THE HIGHEST SCIENTIFIC AND ETHICAL STANDARDS TO PROTECT THE RIGHTS, WELL-BEING, AND DIGNITY OF TRIAL VOLUNTEERS. IAVI HAS ALSO LAUNCHED RESEARCH CONSORTIA TO ADDRESS MAJOR SCIENTIFIC PROBLEMS OF BIOMEDICAL PRODUCT DEVELOPMENT. A SIGNIFICANT PORTION OF THE RESEARCH IAVI SUPPORTS IS CONDUCTED IN DEVELOPING COUNTRIES WHERE THE NEED FOR INFECTIOUS DISEASE PREVENTION IS GREATEST.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$10,062,245ExpenseAmt
Revenue$396,577RevenueAmt
DescCONTRACT MANUFACTURING-RELATED ACTIVITIES: IAVI SUPPORTS EXTERNAL RESEARCHERS BY PROVIDING TECHNICAL AND SCIENTIFIC EXPERTISE TO ACCELERATE THE DEVELOPMENT OF THEIR OWN PRODUCTS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$3,431,323ExpenseAmt
Grant$1,032,654GrantAmt
DescVACCINE ADVOCACY, PUBLIC AFFAIRS, AND POLICY: IAVI WORKS WITH POLICY MAKERS, ADVOCATES, AND REPRESENTATIVES OF THE COMMUNITIES WHERE DISEASE BURDEN IS GREATEST TO SUPPORT SCIENTIFIC RESEARCH AND DEVELOPMENT FOR ACCESSIBLE BIOMEDICAL PREVENTIVES AND TREATMENTS.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$73,542,497TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign OfficeYes (1)ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer EntYes (1)BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (1)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
Info In Schedule O Part VYes (X)InfoInScheduleOPartVInd
IRP Document98IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee196EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryINForeignCountryCd
Foreign CountryKEForeignCountryCd
Foreign CountrySFForeignCountryCd
Foreign CountryUKForeignCountryCd
Foreign CountryNLForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members15GoverningBodyVotingMembersCnt
Independent Voting Member14IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local ChaptersYes (1)LocalChaptersInd
Policies Reference ChaptersYes (1)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PATRICK MOUTONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2128471137PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1125 BROAD STREET NO 9TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (26 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
MARK FEINBERG
PRESIDENT/CEO35.00Yes (X)Yes (X)$553,503$0$30,769
ERIC PAUL GOOSBY
BOARD CHAIR2.00Yes (X)Yes (X)$0$0$0
ANNE M VANLENT
BOARD VICE CHAIR2.00Yes (X)Yes (X)$0$0$0
ROBERT GOLDBERG
BOARD TREASURER1.00Yes (X)Yes (X)$0$0$0
FRANCINE NTOUMI
BOARD MEMBER1.00Yes (X)$0$0$0
MARIJKE WIJNROKS
BOARD MEMBER1.00Yes (X)$0$0$0
RAJEEV VENKAYYA
BOARD MEMBER (FROM 12/18)1.00Yes (X)$0$0$0
PURNIMA MANE
BOARD MEMBER1.00Yes (X)$0$0$0
JIM CONNOLLY
BOARD MEMBER (FROM 12/18)1.00Yes (X)$0$0$0
LINDA-GAIL BECKER
BOARD MEMBER (FROM 1/18)1.00Yes (X)$0$0$0
CHRISTINA HULL PAXSON
BOARD MEMBER (FROM 1/18, UNTIL 6/18)1.00Yes (X)$0$0$0
MARK DYBUL
BOARD MEMBER (FROM 3/18)1.00Yes (X)$0$0$0
MONCEF SLAOUI
BOARD MEMBER (UNTIL 3/18)1.00Yes (X)$0$0$0
DAVID BLUMBERG
BOARD MEMBER (FROM 12/18)1.00Yes (X)$0$0$0
JOHN W SHIVER
BOARD MEMBER (FROM 7/18)1.00Yes (X)$0$0$0
ANNE MARTIN SIMONDS
BOARD MEMBER (FROM 10/18)1.00Yes (X)$0$0$0
JOHN NKENGASONG
BOARD MEMBER (FROM 9/18)1.00Yes (X)$0$0$0
ANA CESPEDES MONTOYA
CHIEF OPERATING OFFICER (FROM 9/18)35.00Yes (X)$113,846$0$23,307
LABEEB ABBOUD
SECRETARY, SR VP, GENERAL COUNSEL35.00Yes (X)$378,295$0$59,950
LOUIS SCHWARTZ
CHIEF FINANCIAL OFFICER35.00Yes (X)$324,722$0$59,950
ANTHONY MUSYOKA
H.R., ASST. SECRETARY (UNTIL 8/18)35.00Yes (X)$244,969$0$49,551
THOMAS HASSELL
V.P. VACCINE DEVELOPMENT R&D35.00$345,158$0$59,950Yes (X)
CHRISTOPHER PARKS
EXECUTIVE DIR., VIRAL VACCINES35.00$313,102$0$59,950Yes (X)
FRANCES PRIDDY
EXECUTIVE DIR, CHIEF MEDICAL OFFICER35.00$299,146$0$59,950Yes (X)
SWATI GUPTA
V.P. RESEARCH INTEGRATION & INNOV.35.00$319,471$0$57,395Yes (X)
MARGARET T KEANE
V.P. GLOBAL ALL. & PRODUCT35.00$311,679$0$48,777Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,203,891TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$509,549TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K88IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmCountryContractorAddress/ForeignAddress/CountryCdForeign PostalContractorAddress/ForeignAddress/ForeignPostalCdProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm
EMMES CORPORATION
401 N WASHINGTON STREETROCKVILLEMD20850CLINICAL RESEARCH STUDIES$765,799
ROUTES 2 RESULTS
VIDEO ETHNOGRAPHY$512,7485 PARK CT PYRFORD RD WEST BYFLEETSURREYUKKT1 46SD
C&G CONSULTING SERVICES INC
186 SAND ROADFAIRFIELDNJ07004TEMP SERVICES$505,954
AUSTRALIAN BIOLOGICS PTY LTD
REGULATORY CONSULTANT$330,878PO BOX 587CRAIGIEBURNAS3064VICTORIA
VEDDER PRICE PC
8677 SOLUTION CENTERCHICAGOIL606778006LEGAL SERVICES$188,537
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K13CntrctRcvdGreaterThan100KCnt
Government Grants$36,081,618GovernmentGrantsAmt
All Other Contributions$39,443,226AllOtherContributionsAmt
Total Contributions$75,524,844TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescCONTRACT SERVICE FEESDesc
Business900099BusinessCd
Total Revenue Column$396,577TotalRevenueColumnAmt
Related Or Exempt Func Income$396,577RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$396,577TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$921,661TotalRevenueColumnAmt
Exclusion$921,661ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISCELLANEOUSDesc
Business900099BusinessCd
Total Revenue Column$349,691TotalRevenueColumnAmt
Exclusion$349,691ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$349,691OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$77,192,773TotalRevenueColumnAmt
Related Or Exempt Func Income$396,577RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,271,352ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$4,961,485TotalAmt
Program Services$4,961,485ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$13,740,118TotalAmt
Program Services$13,740,118ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,838,872TotalAmt
Program Services$197,985ProgramServicesAmt
Management And General$1,599,988ManagementAndGeneralAmt
Fundraising$40,899FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$22,497,547TotalAmt
Program Services$18,313,118ProgramServicesAmt
Management And General$3,710,285ManagementAndGeneralAmt
Fundraising$474,144FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,679,363TotalAmt
Program Services$1,359,380ProgramServicesAmt
Management And General$284,027ManagementAndGeneralAmt
Fundraising$35,956FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,396,967TotalAmt
Program Services$1,913,930ProgramServicesAmt
Management And General$429,687ManagementAndGeneralAmt
Fundraising$53,350FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,407,075TotalAmt
Program Services$1,078,822ProgramServicesAmt
Management And General$298,324ManagementAndGeneralAmt
Fundraising$29,929FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$912,699TotalAmt
Program Services$748,931ProgramServicesAmt
Management And General$163,768ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$161,221TotalAmt
Management And General$161,221ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$228,050TotalAmt
Fundraising$228,050FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$53,575TotalAmt
Management And General$53,575ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$844,497TotalAmt
Program Services$250,730ProgramServicesAmt
Management And General$522,131ManagementAndGeneralAmt
Fundraising$71,636FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$755,974TotalAmt
Program Services$477,125ProgramServicesAmt
Management And General$277,703ManagementAndGeneralAmt
Fundraising$1,146FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$745,879TotalAmt
Program Services$639,497ProgramServicesAmt
Management And General$48,284ManagementAndGeneralAmt
Fundraising$58,098FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,504,349TotalAmt
Program Services$2,856,461ProgramServicesAmt
Management And General$549,507ManagementAndGeneralAmt
Fundraising$98,381FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$2,197,854TotalAmt
Program Services$1,926,878ProgramServicesAmt
Management And General$223,861ManagementAndGeneralAmt
Fundraising$47,115FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$335,922TotalAmt
Program Services$281,804ProgramServicesAmt
Management And General$42,850ManagementAndGeneralAmt
Fundraising$11,268FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$1,490,194TotalAmt
Program Services$1,459,401ProgramServicesAmt
Management And General$26,255ManagementAndGeneralAmt
Fundraising$4,538FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$303,611TotalAmt
Program Services$215,489ProgramServicesAmt
Management And General$85,137ManagementAndGeneralAmt
Fundraising$2,985FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtManagement And GeneralManagementAndGeneralAmtProgram ServicesProgramServicesAmtFundraisingFundraisingAmt
DISALLOWED FRINGE TAX$30,000$30,000
RESEARCH&CLINICAL SVCS.$17,778,408$694$17,753,614$24,100
LAB SUPPLIES/EQUIPMENT$4,610,263$4,610,263
EQUIPMENT MAINT.$622,942$36,254$582,028$4,660

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$286,185TotalAmt
Program Services$175,438ProgramServicesAmt
Management And General$62,003ManagementAndGeneralAmt
Fundraising$48,744FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$83,383,050TotalAmt
Program Services$73,542,497ProgramServicesAmt
Management And General$8,605,554ManagementAndGeneralAmt
Fundraising$1,234,999FundraisingAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$49,308,658BOYAmt
EOY$34,268,115EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$18,982,348BOYAmt
EOY$17,433,290EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$90,200BOYAmt
EOY$121,345EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$180,912BOYAmt
EOY$104,655EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$46,177,971LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$39,763,654LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$7,610,889BOYAmt
EOY$6,414,317EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$5,601,994BOYAmt
EOY$24,861,507EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$184,512BOYAmt
EOY$179,440EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$81,959,513BOYAmt
EOY$83,382,669EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$5,633,347BOYAmt
EOY$7,634,830EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$2,210,932BOYAmt
EOY$2,647,006EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$26,672,679BOYAmt
EOY$32,676,282EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$269,825BOYAmt
EOY$191,015EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,257,445BOYAmt
EOY$3,051,812EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$38,044,228BOYAmt
EOY$46,200,945EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$29,886,074BOYAmt
EOY$26,489,768EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$14,029,211BOYAmt
EOY$10,691,956EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$43,915,285BOYAmt
EOY$37,181,724EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$81,959,513BOYAmt
EOY$83,382,669EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$6,190,277ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$14,673NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$557,957OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$50,593,210CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$71,447,864CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$63,919,808CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$79,435,403CurrentTaxYearMinus1YearAmt
Current Tax Year$75,524,844CurrentTaxYearAmt
Total$340,921,129TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$50,593,210CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$71,447,864CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$63,919,808CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$79,435,403CurrentTaxYearMinus1YearAmt
Current Tax Year$75,524,844CurrentTaxYearAmt
Total$340,921,129TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$128,891,460SubstantialContributorsTotAmt
Public Support Total170$212,029,669PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$775,037CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$694,495CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$538,881CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$596,174CurrentTaxYearMinus1YearAmt
Current Tax Year$921,661CurrentTaxYearAmt
Total$3,526,248TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$587,195CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$505,075CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$116,898CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$234,948CurrentTaxYearMinus1YearAmt
Current Tax Year$349,691CurrentTaxYearAmt
Total$1,793,807TotalAmt
FieldValueIRS element (for citing)
Total Support$346,241,184TotalSupportAmt
Gross Receipts Rltd Activities$1,699,127GrossReceiptsRltdActivitiesAmt
Public Support CY1700.61240PublicSupportCY170Pct
Public Support PY1700.67160PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:FormAndLineReferenceDesc
ExplanationOTHER INCOME - 2014 AMOUNT: $ 70,410. 2015 AMOUNT: $ 146,897. 2016 AMOUNT: $ 54,683. 2017 AMOUNT: $ 100,289. 2018 AMOUNT: $ 232,790. COLLABORATIVE AGREEMENT - 2014 AMOUNT: $ 250,000. RE TAXES REFUND - 2018 AMOUNT: $ 38,091. LOAN FORGIVENESS - 2014 AMOUNT: $ 77,932. 2015 AMOUNT: $ 74,118. 2016 AMOUNT: $ 62,215. 2017 AMOUNT: $ 67,456. 2018 AMOUNT: $ 78,810. WRITE OFF PROVISION FOR RISK - 2014 AMOUNT: $ 188,853. 2015 AMOUNT: $ 284,060. VAT REFUND - 2017 AMOUNT: $ 67,203.ExplanationTxt

Schedule B IRS990ScheduleB

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$228,050FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$228,050FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$83,155,000FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$83,383,050FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$205,000CurrentYearMinus3Amt
Current Year Minus2$227,000CurrentYearMinus2Amt
Current Year Minus1$228,250CurrentYearMinus1Amt
Current Year$228,050CurrentYearAmt
Total$888,300TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$20,053,925OtherCostOrOtherBasisAmt
Depreciation$13,936,937DepreciationAmt
Book Value$6,116,988BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$26,124,046OtherCostOrOtherBasisAmt
Depreciation$25,826,717DepreciationAmt
Book Value$297,329BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$6,414,317TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
DEFERRED RENT$2,519,984
DEFERRED COMPENSATION PAYABLE$531,828
FieldValueIRS element (for citing)
Total Liability$3,051,812TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$78,532,653TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$14,673NetUnrealizedGainsInvstAmt
Other Revenue$1,378,782OtherRevenueAmt
Revenue Not Reported$1,393,455RevenueNotReportedAmt
Revenue Subtotal$77,139,198RevenueSubtotalAmt
Investment Expenses Not Incld$53,575InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$53,575RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$77,192,773TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$83,724,184TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$1,589,094OtherExpensesIncludedAmt
Expenses Not Reported$1,589,094ExpensesNotReportedAmt
Expenses Subtotal$82,135,090ExpensesSubtotalAmt
Investment Expenses Not Incld2$53,575InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$1,194,385OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$1,247,960ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$83,383,050TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART X, LINE 2:FOR THE YEAR ENDED DECEMBER 31, 2018, MANAGEMENT OF IAVI HAS DOCUMENTED ITS CONSIDERATION OF FASB ASC 740-10, INCOME TAXES, THAT PROVIDES GUIDANCE FOR REPORTING UNCERTAINTY IN INCOME TAXES AND HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS.
PART XI, LINE 2D - OTHER ADJUSTMENTS:REVENUE OF STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE -27,404. INCLUDED IN CONSOLIDATED AUDIT REPORT BUT EXCLUDED FOR IAVI FORM 990 REPORTING PURPOSES. REVENUE OF IAVI INDIA, INCLUDED IN CONSOLIDATED AUDIT 1,406,186. REPORT BUT EXCLUDED FOR IAVI FORM 990 REPORTING PURPOSES.
PART XII, LINE 2D - OTHER ADJUSTMENTS:EXPENSES OF STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE 1,081,832. INCLUDED IN CONSOLIDATED AUDIT REPORT BUT EXCLUDED FOR IAVI FORM 990 REPORTING PURPOSES. EXPENSES OF IAVI INDIA, INCLUDED IN CONSOLIDATED AUDIT 153,550. REPORT BUT EXCLUDED FOR FORM 990 REPORTING PURPOSES. EXPENSES OF AERAS, INCLUDED IN CONSOLIDATED AUDIT 353,712. REPORT BUT EXCLUDED FOR FORM 990 REPORTING PURPOSES.
PART XII, LINE 4B - OTHER ADJUSTMENTS:INTER-COMPANY EXPENSES, ELIMINATED IN CONSOLIDATED AUDIT 1,194,385. REPORT BUT INCLUDED IN IAVI, INC. FORM 990.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmtSpecific Services ProvidedSpecificServicesProvidedTxt
EUROPE00GRANTS TO RECIPIENTS LOCATED IN REGION$6,016,128
SOUTH ASIA00GRANTS TO RECIPIENTS LOCATED IN REGION$263,511
SUB-SAHARAN AFRICA00GRANTS TO RECIPIENTS LOCATED IN REGION$7,450,479
NORTH AMERICA00GRANTS TO RECIPIENTS LOCATED IN REGION$10,000
EAST ASIA AND THE PACIFIC00PROGRAM SERVICE ACTIVITIES$324,538RESEARCH/ADVOCACY/POLICY
EUROPE16PROGRAM SERVICE ACTIVITIES$3,601,714RESEARCH/ADVOCACY/POLICY
NORTH AMERICA00PROGRAM SERVICE ACTIVITIES$261,514RESEARCH/ADVOCACY/POLICY
SUB-SAHARAN AFRICA227PROGRAM SERVICE ACTIVITIES$1,405,950RESEARCH/ADVOCACY/POLICY
SOUTH ASIA116PROGRAM SERVICE ACTIVITIES$53,089RESEARCH/ADVOCACY/POLICY
FieldValueIRS element (for citing)
Subtotal Offices3SubtotalOfficesCnt
Subtotal Employees33SubtotalEmployeesCnt
Continuation Total Office1ContinuationTotalOfficeCnt
Continuation Total Employee16ContinuationTotalEmployeeCnt
Total Office4TotalOfficeCnt
Total Employee49TotalEmployeeCnt
Subtotal Spent$19,333,834SubtotalSpentAmt
Continuation Spent$53,089ContinuationSpentAmt
Total Spent$19,386,923TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (28 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
EUROPEVACCINE ADVOCACY, PUBLIC AFFAIRS AND POLICY$1,032,654WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$2,898,160WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$1,442,716WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$1,464,412WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$1,104,211WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$1,122,390WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$738,844WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$718,378WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$547,330WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$446,186WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$482,652WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$386,048WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$252,711WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$172,986WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$137,942WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$136,648WIRE TRANSFER
SOUTH ASIARESEARCH&DEVELOPMENT$134,274WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$128,857WIRE TRANSFER
SOUTH ASIARESEARCH&DEVELOPMENT$92,992WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$76,437WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$76,025WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$161,731WIRE TRANSFER
SOUTH ASIARESEARCH&DEVELOPMENT$36,245WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$27,749WIRE TRANSFER
EUROPERESEARCH&DEVELOPMENT$10,985WIRE TRANSFER
NORTH AMERICARESEARCH&DEVELOPMENT$10,000WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$8,043WIRE TRANSFER
SUB-SAHARAN AFRICARESEARCH&DEVELOPMENT$7,947WIRE TRANSFER
FieldValueIRS element (for citing)
Total501c3 Org24Total501c3OrgCnt
Total Other Org4TotalOtherOrgCnt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION HAS A COMPLIANCE UNIT THAT MONITORS THE ADHERENCE OF SUB-GRANTEES TO THE CONTRACT AND DONOR TERMS WHICH INCLUDES REVIEW OF 2 CFR 200 AND THE FAR. ROUTINE COMPLIANCE AND SUBSTANTIVE AUDITS ARE PERFORMED BY A COMPLIANCE OFFICER LOCATED IN EAST AFRICA. ROUTINE INTERNAL CONTROL QUESTIONNAIRES, AND IN-DEPTH REVIEW OF QUARTERLY REPORTS OF SUB-GRANTEES TAKES PLACE ON A REGULAR BASIS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (13 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
THE SCRIPPS RESEARCH INSTITUTE
10550 NORTH TORREY PINES ROADLA JOLLACA92037330435954501(C)(3)$1,848,541RESEARCH & DEVELOPMENT
INSTITUTE FOR PROTEIN INNOVATION INC
240 LONGWOOD AVENUE BLDG C - ROOMBOSTONMA02115813250208501(C)(3)$894,057RESEARCH & DEVELOPMENT322
EMORY UNIVERSITY
1599 CLIFTON ROADATLANTAGA30332580566256501(C)(3)$715,702RESEARCH & DEVELOPMENT
FRED HUTCHINSON CANCER RESEACH CENTER
1100 FAIRVIEW AVENUE NORTHSEATTLEWA98109237156071501(C)(3)$425,342RESEARCH & DEVELOPMENT
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WETLAKE AVENUE N STE 500SEATTLEWA981095240910961784501(C)(3)$281,134RESEARCH & DEVELOPMENT
UNIVERSITY OF ALABAMA AT BIRMINGHAM
701 20TH STREET S-AB 921BIRMINGHAMAL35294636005396501(C)(3)$170,670RESEARCH & DEVELOPMENT
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
3333 CALIFORNIA STREET SUITE 315SAN FRANCISCOCA94158943067788501(C)(3)$150,396RESEARCH & DEVELOPMENT
GEORGE WASHINGTON UNIVERSITY
45155 RESEARCH PLACE - STE 160ASHBURNVA20147530196584501(C)(3)$140,938RESEARCH & DEVELOPMENT
NORTHWESTERN UNIVERSITY
750 N LAKE SHORE DRIVE 7TH FLOORCHICAGOIL60611362167817501(C)(3)$138,526RESEARCH & DEVELOPMENT
NATIONAL INSTITUTE OF ALLERGY-INFECTIOUS DISEASES
6610 ROCKLEDGE DRIVE RM 2800BETHESDACA208926606530196960GOVERNMENT$100,000RESEARCH & DEVELOPMENT
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NESEATTLEWA98105910961784501(C)(3)$45,403RESEARCH & DEVELOPMENT
UNIVERSITY OF WISCONSIN-MADISON
21 N PARK STREET STE 6401MADISONWI537151218366006492501(C)(3)$24,375RESEARCH & DEVELOPMENT
CHILDREN'S HOSPITAL OF PHILADELPHIA
3535 MARKET STREET 12TH FLOORPHILADELPHIAPA19104231352166501(C)(3)$15,108RESEARCH & DEVELOPMENT
FieldValueIRS element (for citing)
Total501c3 Org13Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION HAS A COMPLIANCE UNIT THAT MONITORS THE ADHERENCE OF SUB-GRANTEES TO THE CONTRACT AND DONOR TERMS WHICH INCLUDES REVIEW OF 2 CFR 200 AND THE FAR. REVIEW OF 2 CFR 200 AUDITS AND IN-DEPTH REVIEW OF QUARTERLY REPORTS OF SUB-GRANTEES TAKES PLACE ON A REGULAR BASIS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (1)SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MARK FEINBERG
PRESIDENT/CEO$501,411$0$45,788$0$6,304$0$30,250$0$519$0$584,272$0$0$0
LABEEB ABBOUD
SECRETARY, SR VP, GENERAL COUNSEL$331,754$0$25,851$0$20,690$0$30,250$0$29,700$0$438,245$0$0$0
LOUIS SCHWARTZ
CHIEF FINANCIAL OFFICER$296,364$0$26,102$0$2,256$0$30,250$0$29,700$0$384,672$0$0$0
ANTHONY MUSYOKA
H.R., ASST. SECRETARY (UNTIL 8/18)$182,151$0$18,193$0$44,625$0$19,851$0$29,700$0$294,520$0$0$0
THOMAS HASSELL
V.P. VACCINE DEVELOPMENT R&D$315,615$0$27,353$0$2,190$0$30,250$0$29,700$0$405,108$0$0$0
CHRISTOPHER PARKS
EXECUTIVE DIR., VIRAL VACCINES$291,513$0$19,783$0$1,806$0$30,250$0$29,700$0$373,052$0$0$0
FRANCES PRIDDY
EXECUTIVE DIR, CHIEF MEDICAL OFFICER$277,302$0$20,428$0$1,416$0$30,250$0$29,700$0$359,096$0$0$0
SWATI GUPTA
V.P. RESEARCH INTEGRATION & INNOV.$292,944$0$24,775$0$1,752$0$30,250$0$27,145$0$376,866$0$0$0
MARGARET T KEANE
V.P. GLOBAL ALL. & PRODUCT$267,195$0$29,250$0$15,234$0$29,477$0$19,300$0$360,456$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 4AANTHONY MUSYOKA RECEIVED SEVERANCE OF $43,706 PURSUANT TO IAVI'S SEVERANCE POLICY.
PART I, LINE 7BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)

Relationship DescriptionRelationshipDescriptionTxtTransactionTransactionAmtTransactionTransactionDescSharing Of RevenuesSharingOfRevenuesInd
NOODLE FOX MEDIA
THE OWNER OF THE ENTITY IS A FAMILY MEMBER (SPOUSE) OF AN OFFICER OF IAVI.$149,527IAVI HAS A CONSULTING AGREEMENT WITH NOODLE FOX MEDIA, TO PROVIDE MANAGING EDITOR SERVICES FOR IAVI REPORT. THE CONSULTANT WAS SELECTED ON A SOLE SOURCE BASIS, DUE TO UNIQUE SKILL AND EXPERIENCE. THE CONSULTANT HAD PREVIOUSLY SERVED AT IAVI AS MANAGING EDITOR FOR IAVI REPORT, AND BROUGHT RELEVANT SUBSTANTIVE KNOWLEDGE, SCIENTIFIC CONTACTS, AND EXPERTISE IN SCIENCE WRITING, EDITING AND MANAGING THE PUBLICATION PROCESS. THE AGREEMENT WAS ESTABLISHED ON AN ARMS-LENGTH BASIS BY THE ORGANIZATION.0
DESMOND TUTU HIV FOUNDATION
AN IAVI BOARD MEMBER IS THE DEPUTY DIRECTOR AND COO OF THE ENTITY.$209,856IAVI HAS A SUB-AWARD AGREEMENT WITH DESMOND TUTU INSTITUTE FOR HIV RESEARCH FOUNDATION.0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BTHE AUDIT AND FINANCE COMMITTEE REVIEWED AND APPROVED THE FORM 990 IN DETAIL WITH THE CONTROLLER AND CFO. IT WAS THEN SENT TO THE FULL BOARD BEFORE IT WAS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CIAVI HAS A CONFLICT OF INTEREST POLICY WHICH APPLIES TO ALL DIRECTORS, OFFICERS, KEY PERSONS, EMPLOYEES, CONSULTANTS AND ADVISORY COMMITTEE MEMBERS. THE POLICY REQUIRES THAT ALL DIRECTORS, OFFICERS, KEY PERSONS, EMPLOYEES AND ADVISORY COMMITTEE MEMBERS FILE AN ANNUAL DISCLOSURE FORM, INDICATING WHETHER THERE ARE ANY POSSIBLE OR ACTUAL CONFLICTS AS DEFINED UNDER THE POLICY. IN ADDITION, ALL ARE REQUIRED TO DISCLOSE ANY POSSIBLE OR ACTUAL CONFLICTS ON AN ONGOING BASIS. ANNUAL DISCLOSURE FORMS, AS WELL OTHER CONFLICT OF INTEREST DISCLOSURES THAT ARISE DURING THE YEAR, ARE FILED WITH AND REVIEWED BY THE GENERAL COUNSEL'S OFFICE. IN ADDITION, THE AUDIT & FINANCE COMMITTEE REVIEWS CONFLICT OF INTEREST DISCLOSURES THAT INVOLVE A DIRECTOR, OFFICER, OR KEY PERSON. IN EACH CASE, THE REVIEW ENSURES THAT ANY CONFLICT OF INTEREST OR POSSIBLE CONFLICT OF INTEREST IS PROPERLY ADDRESSED, MITIGATED, AND/OR MANAGED. CONFLICT OF INTEREST DISCLOSURES ARE SUMMARIZED AND PROVIDED TO THE CHAIR OF THE AUDIT & FINANCE COMMITTEE FOR REVIEW BY THE AUDIT & FINANCE COMMITTEE. IF ANY CONFLICT OF INTEREST OR POSSIBLE CONFLICT OF INTEREST DISCLOSURE INVOLVES THE CHAIR OF THE AUDIT & FINANCE COMMITTEE, THE COMMITTEE MEETS WITHOUT THE CHAIR.
FORM 990, PART VI, SECTION B, LINE 15ONCE EVERY TWO YEARS, THE COMPENSATION COMMITTEE OF THE BOARD, COMMISSIONS A COMPENSATION SURVEY OF THE CEO'S COMPENSATION PACKAGE. THE SURVEY COMPARES COMPENSATION PACKAGES OF CEOS OF ORGANIZATIONS THAT ARE COMPARABLE TO IAVI. THE COMMITTEE REVIEWS THE RESULTS OF THE SURVEY AND RECOMMENDATIONS MADE, DISCUSSES THIS WITH THE BOARD BEFORE PROVIDING SPECIFIC GUIDANCE AND APPROVAL TO IAVI'S MANAGEMENT. THE COMPENSATION COMMITTEE DETERMINES THE APPROPRIATE PACKAGE FOR THE CEO AND THE BOARD CHAIR SHARES THIS INFORMATION WITH HUMAN RESOURCES FOR IMPLEMENTATION. IAVI ENGAGES AN EXTERNAL SPECIALIZED FIRM WITH EXPERTISE TO CONDUCT THE SURVEY AND PROVIDE RECOMMENDATION TO THE COMPENSATION COMMITTEE. THE DELIBERATIONS OF THE COMPENSATION COMMITTEE OF THE BOARD ARE DOCUMENTED IN THE COMPENSATION COMMITTEE MINUTES FOR EACH MEETING OF THE MEMBERS. ALSO THE SAME IS CAPTURED IN THE BOARD MINUTES AS REPORTED OUT BY THE COMPENSATION COMMITTEE CHAIR FOR BOARD DISCUSSIONS AND APPROVAL. THE LAST COMPENSATION REVIEW TOOK PLACE IN DECEMBER 2018. IN CONJUNCTION WITH THE CEO'S COMPENSATION REVIEW, THE COMPENSATION COMMITTEE OF THE BOARD ALSO COMMISSIONS AN EXTERNAL COMPARATIVE COMPENSATION SURVEY OF ORGANIZATIONS SIMILAR TO IAVI, IN WHICH THE PACKAGES OF ALL OTHER OFFICERS AND KEY EMPLOYEES ARE BENCHMARKED AGAINST THE LABOR MARKET TO DETERMINE APPROPRIATENESS OF PAY. THE COMMITTEE REVIEWS THE RESULTS AND RECOMMENDATIONS FROM THIS SURVEY AND PROVIDES MANAGEMENT WITH SPECIFIC GUIDANCE IN ADDRESSING ANY DISPARITIES. USING BENCHMARK JOB CLASSIFICATIONS, ONCE EVERY 2 YEARS IAVI COMMISSIONS A COMPENSATION SURVEY, ACROSS ALL ITS OFFICES TO DETERMINE THE COMPETITIVENESS OF ITS COMPENSATION PROGRAMS AND TO ENABLE THE ORGANIZATION TO CONTINUE TO ATTRACT AND RETAIN THE RIGHT TALENT IN THESE VARIOUS MARKETS. IN MOST CASES THE LOCAL LABOR MARKET IS CONSIDERED AND FOR CERTAIN POSITIONS, REGIONAL MARKETS MUST BE TARGETED. THE RESULTS OF EACH SURVEY ARE REVIEWED WITH THE COMPENSATION COMMITTEE OF THE BOARD, WHICH GIVES MANAGEMENT OVERALL GUIDANCE ON COMPENSATION DIRECTION. BASED ON RECOMMENDATIONS AND GUIDANCE OF THE COMPENSATION COMMITTEE, THE EXECUTIVE OFFICE AND HUMAN RESOURCES COMMUNICATE CHANGES TO ANY AFFECTED EMPLOYEES. ANY COMPENSATION CHANGES ARE DETERMINED BASED ON EXTERNAL COMPETIVENESS RELATIVE INTERNAL VALUE, INDIVIDUAL PERFORMANCE, TEAM DYNAMIC, AND IAVI'S ABILITY TO PAY.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE ON ITS WEBSITE.
FORM 990, PART XI, LINE 9:FOREIGN EXCHANGE LOSS -604,253. GRANT TO AERAS ELIMINATED IN CONSOLIDATION 46,296.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1IAVI LAB LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1125 BROAD STREET 9TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
EIN262031769EIN
Primary ActivitiesLAB RESEARCHPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd
Total Income$0TotalIncomeAmt
End Of Year Assets$5,407,738EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1IAVI INCBusinessNameLine1Txt

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile Foreign CountryLegalDomicileForeignCountryCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationIndProvince Or StateForeignAddress/ProvinceOrStateNm
STICHTING IAVI
VAN DIEMENSTRAAT 48 1013 NHAMSTERDAMNLRESEARCH SUPPORTNLN/AN/AIAVI INCYes (1)
IAVI INDIA
4 FACTORY ROAD GROUND FLOORANSARI NAGAR WESTINRESEARCH SUPPORTINN/AN/AIAVI INCYes (1)NEW DELHI-110029
AERAS GLOBAL TB VACCINE FOUNDATION NPC
BLACK RIVER PARK 2 FIR ST OBSERVACAPETOWNSFRESEARCH SUPPORTSFN/AN/AIAVI INCYes (1)

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1IAVI HOLDING LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1125 BROAD STREET 9TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10004ZIPCd
FieldValueIRS element (for citing)
EIN262032322EIN
Primary ActivitiesHOLDING COMPANYPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1IAVI INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Entity TypeCEntityTypeTxt
Ownership1.00000OwnershipPct
Controlled OrganizationYes (1)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (2 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
STICHTING IAVI
B$1,032,654ACTUAL
AERAS GLOBAL TB VACCINE FOUNDATION NPC
B$161,731ACTUAL

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE R, PART II:FormAndLineReferenceDesc
ExplanationEFFECTIVE AS OF OCTOBER 1, 2018, IAVI COMPLETED AN ACQUISITION OF THE MAJORITY OF THE REMAINING ASSETS OF AERAS, A NON-PROFIT CORPORATION FORMED UNDER THE LAWS OF THE DISTRICT OF COLUMBIA, THAT HAS FOCUSED ON THE ADVANCEMENT OF TB VACCINE RESEARCH AND DEVELOPMENT AND IAVI ALSO ASSUMED CONTROL OF AN AERAS AFFILIATED ENTITY IN SOUTH AFRICA, THE AERAS GLOBAL TB VACCINE FOUNDATION (AERAS S.A.), THROUGH THE ASSUMPTION OF CONTROL OVER THE APPOINTMENT OF THE DIRECTORS OF THE SOUTH AFRICAN ENTITY. THE PURPOSE OF THE ASSET TRANSFER WAS TO ACQUIRE THE REMAINING TB VACCINE PROGRAMS OF AERAS, INCORPORATE THEM INTO IAVI IN A MANNER THAT WOULD STRENGTHEN IAVI'S GLOBAL CLINICAL DEVELOPMENT CAPABILITIES AND ENABLE IAVI TO ADVANCE THE CLINICAL DEVELOPMENT OF TB VACCINE CANDIDATES. THE ASSET TRANSFER WAS EFFECTED THROUGH AN ASSET TRANSFER AGREEMENT (ATA) DATED AS OF SEPTEMBER 30, 2018, BETWEEN AERAS AND IAVI. PURSUANT TO THE ATA, IAVI ACQUIRED THE RIGHT, TITLE AND INTEREST TO THE MAJORITY OF THE REMAINING AERAS' ASSETS, AS OF THE EFFECTIVE DATE, WHICH INCLUDED THE REMAINING PROGRAMMATIC ACTIVITIES, PROPERTIES, GOODWILL AND RIGHTS OWNED, LEASED OR LICENSED BY AERAS. AS OF DECEMBER 2018, IAVI APPOINTED TWO OF THE AERAS DIRECTORS TO THE IAVI BOARD OF DIRECTORS. IAVI DID NOT MAKE ANY PAYMENT TO AERAS IN CONNECTION WITH THE ACQUISITION OF THE AERAS ASSETS. IAVI DID RECEIVE CERTAIN FINANCIAL ASSETS (INCLUDING FINANCIAL PAYMENTS) FROM AERAS IN CONNECTION WITH THE ATA.ExplanationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.